<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <cosponsors />
    <latestAction>
      <actionDate>2014-12-11</actionDate>
      <links />
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </latestAction>
    <amendments />
    <laws />
    <createDate>2014-12-12T05:02:15Z</createDate>
    <summaries>
      <billSummaries>
        <item>
          <lastSummaryUpdateDate>2015-01-05T20:36:13Z</lastSummaryUpdateDate>
          <text><![CDATA[<p> Amends the Federal Food, Drug, and Cosmetic Act to declare that nothing in it or in the Public Health Service Act shall prevent or restrict, and the Food and Drug Administration (FDA) shall not implement or enforce any law to prevent or restrict, the importation, distribution, or sale of investigational drugs or devices for terminally ill patients.</p>]]></text>
          <updateDate>2014-12-11T05:00:00Z</updateDate>
          <actionDesc>Introduced in House</actionDesc>
          <name>Introduced in House</name>
          <versionCode>00</versionCode>
          <actionDate>2014-12-11</actionDate>
        </item>
      </billSummaries>
    </summaries>
    <constitutionalAuthorityStatementText><![CDATA[<pre>By Mr. GRAYSON:H.R. 5854.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8 of the U.S. Constitution.[Page H9303]</pre>]]></constitutionalAuthorityStatementText>
    <titles>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <title>To allow the importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients who execute an informed consent document.</title>
      </item>
      <item>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Display Title</titleType>
        <title>To allow the importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients who execute an informed consent document.</title>
      </item>
    </titles>
    <calendarNumbers />
    <updateDate>2016-10-25T16:17:48Z</updateDate>
    <introducedDate>2014-12-11</introducedDate>
    <recordedVotes />
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Health technology, devices, supplies</name>
          </item>
          <item>
            <name>Long-term, rehabilitative, and terminal care</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
          <item>
            <name>Retail and wholesale trades</name>
          </item>
          <item>
            <name>Trade restrictions</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <actions>
      <item>
        <actionCode>H11100</actionCode>
        <type>IntroReferral</type>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <actionDate>2014-12-11</actionDate>
        <links />
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <actionCode>Intro-H</actionCode>
        <type>IntroReferral</type>
        <text>Introduced in House</text>
        <actionDate>2014-12-11</actionDate>
        <links />
        <committee />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <item>
        <actionCode>1000</actionCode>
        <type>IntroReferral</type>
        <text>Introduced in House</text>
        <actionDate>2014-12-11</actionDate>
        <links />
        <committee />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
      <actionByCounts>
        <houseOfRepresentatives>3</houseOfRepresentatives>
      </actionByCounts>
      <actionTypeCounts>
        <billReferrals>1</billReferrals>
        <introducedInHouse>1</introducedInHouse>
        <introducedInTheHouse>1</introducedInTheHouse>
      </actionTypeCounts>
    </actions>
    <originChamber>House</originChamber>
    <committees>
      <billCommittees>
        <item>
          <name>Energy and Commerce Committee</name>
          <type>Standing</type>
          <subcommittees />
          <chamber>House</chamber>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2014-12-11T14:01:30Z</date>
            </item>
          </activities>
          <systemCode>hsif00</systemCode>
        </item>
      </billCommittees>
    </committees>
    <cboCostEstimates />
    <billType>HR</billType>
    <billNumber>5854</billNumber>
    <committeeReports />
    <notes />
    <title>To allow the importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients who execute an informed consent document.</title>
    <congress>113</congress>
    <sponsors>
      <item>
        <lastName>Grayson</lastName>
        <fullName>Rep. Grayson, Alan [D-FL-9]</fullName>
        <byRequestType />
        <identifiers>
          <gpoId>7302</gpoId>
          <bioguideId>G000556</bioguideId>
          <lisID>1914</lisID>
        </identifiers>
        <bioguideId>G000556</bioguideId>
        <firstName>Alan</firstName>
        <middleName />
      </item>
    </sponsors>
    <relatedBills>
      <item>
        <number>4475</number>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <congress>113</congress>
        <latestAction>
          <actionDate>2014-04-11</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <latestTitle>Compassionate Freedom of Choice Act of 2014</latestTitle>
        <type>HR</type>
      </item>
    </relatedBills>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

